A Single-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Assessing the Muscular strength increase effects of Heat-Killed Bifidobacterium supplementation in patients of sarcopenia

Asaoka Daisuke0 个研究点目标入组 100 人开始时间: 2020年11月13日最近更新: 2023年10月17日

试验速览

阶段: 未知
状态: 招募中
发起方
入组人数: 100

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: >= 50age old 至 < 90age old（—）
性别: All

入选标准

•(1)The age at agreement acquisition is man and woman younger than 90 years 50 years old or older
•(2)1 or 2 or both concretely following correspond and the patient whom sarcopenia was diagnosed in by the sarcopenia diagnosis that Asian Working Group for Sarcopenia proposes correspond to 3 AWGS 2019
•1.A grip drop Male <28kg, woman <18kg
•2.A walking speed drop <1.0 m/sec
•3.By the measurement of the quantity of muscle the drop (male <7.0 kg/m2, woman <5.4 kg/m2) of the skeletal muscle mass index (SMI) by the DXA method
•(3)Written informed consent is provided about the participation in this study.

排除标准

•1. When there is the head injury that left Parkinson's disease, Huntington disease, original ordinary pressure hydrocephalus, progressive supranuclear paralysis, epilepsy, multiple sclerosis, intracranial infectious disease, aftereffects.
•2. When there is the past of major depression and bipolar disorder, alcohol and other drug dependency.
•3. When frequent occurrence cerebral infarction, a brain tumor, an endocranium bloody bowel discharge tumor are detected.
•4. In the case of dementia.
•5. In the case of neurologic syphilis.
•6. When there are exercise restrictions by a disease of joint.
•7. The person who is infected with the infectious diseases that serious cerebro-vascular disease, heart trouble, liver disease, renal disease, a digestive organ disease, an internal secretion metabolism disease, a report need.
•8. A person with a history of the past of the gastrointestinal advanced cancer or the person who is receiving treatment, medication because of the disease now.
•9. The person with a history of the operation big to gastric resection, the stomach and intestines suture, alimentary system including the intestinal tract excision.
•10. A person having a digestive organs disorder such as the inflammatory bowels syndrome.
•11. Pharmaceutical products (antibiotic, medicine for intestinal disorders, aperient, binding medicine) and supplement (a person using a bifidus bacillus regularly, which affect the bowel movement
•12. The person who might show an allergic symptom for a drug or food.
•13. A habitual user of excessive smoking and the alcohol and the person that lifestyles such as a meal, the sleep are extremely irregular.
•14. When I take antidementia medicine, psychotropic drug (antidepressant, antipsychotic).
•15. When, having severe diabetes, I give insulin.
•16. When I work on resistance
•17. In addition, when I recognize it being to if a study responsibility doctor is inadequate.

研究者

发起方

Asaoka Daisuke

相似试验

进行中（未招募）

1 期

A single center randomised placebo controlled study to test a novel topical formulation containing Niclosamide, an antibiotic.AntibioTx has developed a topical product (ATx201) for treatment of infected eczema and infected atopic dermatitis. These infections are predominantly caused by Staphyllococcus aureus and various species of Streptococcus. Treatment of these infections is plagued by inactivity of or resistance towards the main topical antibiotics (fucidic acid, mupirocin and retapamulin).MedDRA version: 20.0Level: HLTClassification code 10040788Term: Skin and subcutaneous tissue bacterial infectionsSystem Organ Class: 100000004858

EUCTR2016-003501-33-ATAntibioTx ApS76

已完成

1 期

Study of efficacy and safety of KSM-66 Ashwagandhaa (Withania somnifera Dunal) in stress and anxiety and on general well being in healthy adults.

CTRI/2011/091/000222Ixoreal Biomed Priavte Limited,#5-9-225, 3rd floor, Sanali estate, Chirag ali lane, Abids,Hyderabad, Andhra Pradesh- 500001, India60

进行中（未招募）

1 期

A single-center, prospective, randomized, double-blind, intra-patient (left-to-right) placebo-controlled, pilot study to assess the efficacy and safety of a betamethasone valerate 0.1% medicated plaster in the treatment of finger nail psoriasisail Psoriasis

EUCTR2014-000291-25-ITIBSA Institut Biochimique S.A.30

已完成

3 期

Effect of PMZ-2010 in Hypovolemic Shock patients.

CTRI/2019/01/017196Pharmazz India Private Limited105

尚未招募

不适用

A Clinical study to evaluate the Safety and Efficacy of CurQfen in mild to moderate Knee Osteoarthritis Patients.

CTRI/2019/03/017954Akay Flavours and Aromatics Private Limited